ALB and tuberculosis: Interestingly, the combination of dapagliflozin and silymarin led to a significant decrease (p < 0.001) in the serum levels of ALT, AST, and TB, and a significant increase in albumin levels (p < 0.001) compared to the cisplatin-intoxicated hepatotoxic control group.